State Street’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $261M | Buy |
826,539
+47,683
| +6% | +$11.2M | 0.01% | 885 |
|
|
2026
Q1 | $155M | Buy |
778,856
+27,651
| +4% | +$5.47M | 0.01% | 1100 |
|
|
2025
Q4 | $142M | Buy |
751,205
+1,845
| +0.2% | +$355K | ﹤0.01% | 1153 |
|
|
2025
Q3 | $133M | Sell |
749,360
-394
| -0.1% | -$58.6K | ﹤0.01% | 1180 |
|
|
2025
Q2 | $85.2M | Buy |
749,754
+22,629
| +3% | +$2.42M | ﹤0.01% | 1394 |
|
|
2025
Q1 | $76.4M | Sell |
727,125
-16,507
| -2% | -$1.87M | ﹤0.01% | 1408 |
|
|
2024
Q4 | $79.7M | Buy |
743,632
+36,218
| +5% | +$4.09M | ﹤0.01% | 1481 |
|
|
2024
Q3 | $70.8M | Buy |
707,414
+18,642
| +3% | +$1.88M | ﹤0.01% | 1521 |
|
|
2024
Q2 | $58M | Buy |
688,772
+17,488
| +3% | +$1.39M | ﹤0.01% | 1587 |
|
|
2024
Q1 | $49.1M | Buy |
671,284
+3,000
| +0.4% | +$221K | ﹤0.01% | 1739 |
|
|
2023
Q4 | $47.7M | Buy |
668,284
+45,029
| +7% | +$2.66M | ﹤0.01% | 1727 |
|
|
2023
Q3 | $37.3M | Buy |
623,255
+10,643
| +2% | +$701K | ﹤0.01% | 1794 |
|
|
2023
Q2 | $44.2M | Sell |
612,612
-32,946
| -5% | -$2.47M | ﹤0.01% | 1748 |
|
|
2023
Q1 | $47.5M | Sell |
645,558
-4,356
| -0.7% | -$310K | ﹤0.01% | 1682 |
|
|
2022
Q4 | $43.4M | Sell |
649,914
-875,049
| -57% | -$56.9M | ﹤0.01% | 1734 |
|
|
2022
Q3 | $81.9M | Sell |
1,524,963
-212,556
| -12% | -$12.5M | 0.01% | 1247 |
|
|
2022
Q2 | $96.7M | Sell |
1,737,519
-12,625
| -0.7% | -$716K | 0.01% | 1169 |
|
|
2022
Q1 | $123M | Buy |
1,750,144
+327,717
| +23% | +$23.8M | 0.01% | 1150 |
|
|
2021
Q4 | $137M | Sell |
1,422,427
-49,468
| -3% | -$4.57M | 0.01% | 1060 |
|
|
2021
Q3 | $128M | Buy |
1,471,895
+94,200
| +7% | +$7.29M | 0.01% | 1078 |
|
|
2021
Q2 | $113M | Buy |
1,377,695
+122,931
| +10% | +$10.2M | 0.01% | 1206 |
|
|
2021
Q1 | $119M | Sell |
1,254,764
-613,356
| -33% | -$58M | 0.01% | 1103 |
|
|
2020
Q4 | $116M | Buy |
1,868,120
+310,602
| +20% | +$17.7M | 0.01% | 1040 |
|
|
2020
Q3 | $92.6M | Sell |
1,557,518
-61,813
| -4% | -$4.22M | 0.01% | 1015 |
|
|
2020
Q2 | $113M | Sell |
1,619,331
-388,840
| -19% | -$24.7M | 0.01% | 877 |
|
|
2020
Q1 | $91.1M | Sell |
2,008,171
-1,529
| -0.1% | -$86.7K | 0.01% | 904 |
|
|
2019
Q4 | $131M | Sell |
2,009,700
-27,216
| -1% | -$1.82M | 0.01% | 881 |
|
|
2019
Q3 | $126M | Buy |
2,036,916
+150,244
| +8% | +$9.43M | 0.01% | 868 |
|
|
2019
Q2 | $134M | Sell |
1,886,672
-182,012
| -9% | -$13.4M | 0.01% | 863 |
|
|
2019
Q1 | $162M | Buy |
2,068,684
+457,775
| +28% | +$34.7M | 0.01% | 746 |
|
|
2018
Q4 | $136M | Buy |
1,610,909
+232,151
| +17% | +$24.7M | 0.01% | 754 |
|
|
2018
Q3 | $236M | Sell |
1,378,758
-81,137
| -6% | -$12.2M | 0.02% | 648 |
|
|
2018
Q2 | $189M | Sell |
1,459,895
-63,418
| -4% | -$7.08M | 0.02% | 713 |
|
|
2018
Q1 | $157M | Sell |
1,523,313
-27,633
| -2% | -$2.73M | 0.01% | 780 |
|
|
2017
Q4 | $132M | Buy |
1,550,946
+184,522
| +14% | +$16M | 0.01% | 861 |
|
|
2017
Q3 | $116M | Buy |
1,366,424
+65,378
| +5% | +$5.18M | 0.01% | 902 |
|
|
2017
Q2 | $98.5M | Sell |
1,301,046
-61,943
| -5% | -$4.33M | 0.01% | 972 |
|
|
2017
Q1 | $90M | Buy |
1,362,989
+2,053
| +0.2% | +$135K | 0.01% | 1012 |
|
|
2016
Q4 | $86.3M | Sell |
1,360,936
-36,208
| -3% | -$2.28M | 0.01% | 981 |
|
|
2016
Q3 | $88.9M | Buy |
1,397,144
+215,728
| +18% | +$15.8M | 0.01% | 940 |
|
|
2016
Q2 | $87.9M | Buy |
1,181,416
+59,656
| +5% | +$4.43M | 0.01% | 896 |
|
|
2016
Q1 | $74.9M | Buy |
1,121,760
+103,249
| +10% | +$6.28M | 0.01% | 965 |
|
|
2015
Q4 | $68.9M | Buy |
1,018,511
+71,779
| +8% | +$4.43M | 0.01% | 997 |
|
|
2015
Q3 | $50.6M | Sell |
946,732
-22,645
| -2% | -$1.37M | 0.01% | 1167 |
|
|
2015
Q2 | $61M | Sell |
969,377
-68,303
| -7% | -$3.73M | 0.01% | 1146 |
|
|
2015
Q1 | $49.9M | Sell |
1,037,680
-34,831
| -3% | -$1.33M | 0.01% | 1242 |
|
|
2014
Q4 | $35.6M | Buy |
1,072,511
+34,871
| +3% | +$1.13M | ﹤0.01% | 1403 |
|
|
2014
Q3 | $30.4M | Buy |
1,037,640
+120,750
| +13% | +$4.01M | ﹤0.01% | 1436 |
|
|
2014
Q2 | $35.6M | Sell |
916,890
-28,032
| -3% | -$1.14M | ﹤0.01% | 1406 |
|
|
2014
Q1 | $39.6M | Sell |
944,922
-63,301
| -6% | -$2.64M | ﹤0.01% | 1328 |
|
|
2013
Q4 | $33.1M | Sell |
1,008,223
-213,265
| -17% | -$6.95M | ﹤0.01% | 1432 |
|
|
2013
Q3 | $33M | Buy |
1,221,488
+403,762
| +49% | +$11.4M | ﹤0.01% | 1396 |
|
|
2013
Q2 | $19.1M | Buy |
+817,726
| New | +$14.7M | ﹤0.01% | 1658 |
|
Other funds holding LGND
JT
CAM
NAMI
State Street's LGND Position: Q2 2026 in Review
State Street increased its Ligand Pharmaceuticals (LGND) stake by 6.1% in Q2 2026, buying an estimated $11.2M and bringing the position to 826,539 shares worth $261M. The position accounts for 0.01% of the portfolio, ranked #885.
State Street first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- State Street held 826,539 shares of Ligand Pharmaceuticals worth $261M as of Q2 2026.
- State Street bought 47,683 Ligand Pharmaceuticals shares in Q2 2026, an estimated $11.2M.
- Ligand Pharmaceuticals made up 0.01% of State Street's portfolio in Q2 2026, its #885 holding.
- State Street first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.